PreveCeutical Medical Inc. (18H.F)

0.0100 0.0000 (0.00%) At close: 08:06AM CEST

PreveCeutical Medical Inc.

885 Cambie Street
Suite 2500
Vancouver, BC V6B 0R6
Canada
604 416 7777
https://www.preveceutical.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Stephen Van Deventer	Chairman, CEO & CFO	83.53k	N/A	1969
Dr. Makarand Jawadekar Ph.D.	Chief Science Officer, President & Director	50.98k	N/A	1951
Mr. Shawn Sadler	Head of Artificial Intelligence	N/A	N/A	N/A

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.

Corporate governance

PreveCeutical Medical Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.